Over the past couple of months, work has progressed on the HAEi Virtual Workshop for the Middle East, North Africa, and Sub Sahara Africa. We have finalized the video recordings, and I have been working with the Regional Patient Advocate for Central Eastern Europe, Benelux, and the Middle East on the new website for the Middle East and North Africa. This will be a fantastic event and a great resource, and we are pleased that we have received participation confirmation from a number of doctors in the regions.
HAEi TrackR has been translated into Portuguese and Spanish, and I have informed all countries in my region that it is now available. The member organization in Spain has been promoting this via its social media channels and newsletter, as have other countries. HAEi has also launched Advocacy Academy, which is available to individual patients and member organizations, and we have been working on promoting this.
The emergency room poster is now available for Portugal, Israel, Libya, and Mauritania, which will help to raise awareness of HAE in emergency settings.
I have been working with doctors in Portugal to produce and present a letter to the Ministry of Health and the Drug Authorities and supporting Spain in preparing for the annual meeting and patient courses, which we hope will commence after the summer. Work is also progressing in setting up the HAE group in Tunisia and creating their website.
In June, the 12th Euro-African Congress of Allergy and Clinical Immunology took place in Algiers, Algeria, with a session on HAE in Children and Adults, with Professor Laurence Bouillet from France.
Lastly, I am pleased to announce that Ruconest has been accepted by the Commission of Pharmacists from Hospital La Paz in Spain and will be available in Madrid soon. Working with the pharmaceutical company, we are hoping that shortly this will be available in other regions too.
